American society of nuclear cardiology position papers

Journal of Nuclear Cardiology

Volumn 5, Issue 2, 1998, Pages 218-231

  DePuey, E Gordon ^a   Port, Steven ^b   Wackers, Frans J Th ^c   Rozanski, Alan ^a   Botvinick, Elias H ^d   Dae, Michael W ^d   Tamaki, Nagara ^e   Edgerton, Dawn ^f  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOKKAIDO UNIVERSITY   (Japan)

^f American Society of Nuclear Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

CARDIOLOGY; IMAGING; NUCLEAR MEDICINE; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; REVIEW; SCINTIANGIOGRAPHY; AMBULATORY MONITORING; ARTICLE; HEART DISEASE; HEART MUSCLE; HUMAN; MENTAL STRESS; METABOLISM; METHODOLOGY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; FATTY ACIDS; HEART DISEASES; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MONITORING, AMBULATORY; MYOCARDIUM; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; STRESS, PSYCHOLOGICAL;

EID: 0032018980     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(98)90206-9     Document Type: Article

References (88)

1. Port S. First-pass radionuclide angiography. In: Skorton, Schelbert, Wolf, Brundage, editors. Marcus cardiac imaging, a companion to Braunwald's heart disease. Volume 2. 2nd ed. p 923-41.
2. Palmas W, Friedman JD, Kiat H, et al. Incremental value of simultaneous assessment of myocardial function and perfusion with technetium-9m sestamibi for prediction of extent of coronary artery disease. J Am Coll Cardiol 1995;25:1024-31.
3. Borges-Neto S, Shaw L, Kesler K, et al. Prediction of severe coronary artery disease by combined rest and exercise radionuclide angiocardiography and tomographic perfusion imaging with technetium 99m-labelled sestamibi: a comparison with clinical and electrocardiographic data. J Nucl Cardiol 1997;4:189-94.
4. Nichols K, DePuey EG, Gooneratne N, Salensky H, Friedman M, Cochoff S. First-pass ventricular ejection fraction using a single-crystal nuclear camera. J Nucl Med 1994;35:1292-300.
5. Moore ML, Murphy PH, Burdine JA. ECG-gated emission computed tomography of the cardiac blood pool. Radiology 1980;134:233-5.
6. Corbett JR. Gated blood-pool SPECT. In: DePuey EG, Berman DS, Garcia EV, editors. Cardiac SPECT imaging. New York: Raven Press; 1995. p 257-73.
7. Berger HJ, Zaret BL. Beat-to-beat left ventricular performance assessed from equilibrium cardiac blood pool using a computerized nuclear probe. Circulation 1981;67:133-6.
8. Zaret BL, Wackers FJ. Nuclear cardiology, II. N Engl J Med 1993;329:855-63.
9. Wilson RA, Sullivan PJ, Moore RH, et al. An ambulatory ventricular function monitor: validation and preliminary clinical results. Am J Cardiol 1983;52:601-6.
10. Zaret BL, Jain D. Continuous monitoring of left ventricular function with miniaturized nonimaging detectors. In: Zaret BL, Beller GA, editors. Nuclear cardiology: state of the art and future directions. St. Louis: Mosby-Year Book; 1993. p 137-45.
11. Broadhurst P, Cashman P, Raftery EB, Lahiri A. Clinical validation of a miniature nuclear probe system for continuous online monitoring of cardiac function and ST-segment. J Nucl Med 1991;32:37-42.
12. Jain D, Allam AH, Wackers FJ, Zaret BL. Validation of a new nonimaging miniature probe for serial on-line left ventricular ejection fraction [abstract]. J Nucl Med 1991:32(suppl):1038.
13. Cohn PF. Myocardial dysfunction in silent myocardial ischemia as demonstrated by ambulatory radionuclide left ventricular function studies. Cardiol Clin 1992;10:473-8.
14. Tamaki N, Yasuda T, Moore R, Gill JB, Coucher CA, Hutter AM, et al. Continuous monitoring of left ventricular function by an ambulatory radionuclide detector in patients with coronary artery disease. J Am Coll Cardiol 1988; 12:669-79.
15. Mohiuddin IH, Kambara H, Ohkusa T, Nohara R, Fudo T, Ono S, et al. Clinical evaluation of cardiac function by ambulatory ventricular scintigraphic monitoring (VEST): validation and study of the effects of nitroglycerin and nifedipine in patients with and without coronary artery disease. Am Heart J 1992;123:386-94.
16. Kayden DA, Remetz MS, Cabin HS, et al. Validation of continuous radionuclide left ventricular function monitoring in detecting silent myocardial ischemia during balloon angioplasty of the left anterior descending artery. Am J Cardiol 1991;67:1339-43.
17. Tamaki N, Gill JB, Moore RH, Yasuda T, Boucher CA, Strauss HW. Cardiac response to daily activities and exercise in normal subjects assessed by an ambulatory ventricular function monitor. Am J Cardiol 1987;59:1164-9.
18. Bairy N, Yang LD, Berman DS, Rozanski A. Comparison of physiological ejection fraction response to activities of daily living: implications for clinical testing. J Am Coll Cardiol 1990;16:847-54.
19. Mortelmans L, Cabrera EZ, Dorny N, Thoeng J, Wauters M, van de Werf F, VanHaecke J, de Roo M, de Geest H. Left ventricular function changes during pharmacological and physiological interventions and routine activities monitored in healthy volunteers by a portable radionuclide probe (VEST). Int J Card Imag 1991;7:79-87.
20. Imbriaco M, Cuocolo A, Pace L, Nappi A, Nicolai E, Maurea S, et al. Repeatability of hemodynamic responses to cardiac stimulations by ambulatory monitoring of left ventricular function. J Nucl Biol Med 1993;37:238-44.
21. Breisblatt W, Weiland FL, McLain JR, Tomlinson GC, Burns MJ, Spaccavento LJ. Usefulness of ambulatory radionuclide monitoring of left ventricular function early after acute myocardial infarction for predicting residual myocardial ischemia. Am J Cardiol 1988;62:1005-10.
22. Kayden D, Wackers FJTh, Zaret BL. Silent left ventricular dysfunction during routine activity after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 1990;15:1500-7.
23. Sheldahl LM, Wilke NA, Dougherty S, Levandoski S, et al. Response to snow shoveling in men with and without ischemic heart disease [abstract]. J Am Coll Cardiol 1991;17:94A.
24. Sheldahl LM, Wilke NA, Dougherty S, Tristani FE. Cardiac response to combined moderate heat and exercise in men with coronary artery disease. Am J Cardiol 1992;70:186-91.
25. Vassiliadis IV, Machac J, Sharma S, Horowitz SF, Goldsmith SJ. Detection of silent left ventricular dysfunction during daily activities in coronary artery disease patients by the nuclear VEST. J Nucl Biol Med 1993;37:198-206.
26. Mohiuddin IH, Tamaki N, Kambara H, Nohara R, Ono S, Okuda K, et al. Detection of exercise-induced silent ischemia and the sequence of ischemic events in coronary artery disease by radionuclide ambulatory ventricular function monitoring. Jpn Circ J 1994;58:689-97.
27. Burg MM, Jain D, Soufer R, Kerns RD, Zaret BL. Role of behavioral and psychological factors in mental stress-induced silent left ventricular dysfunction in coronary artery disease. J Am Coll Cardiol 1993;22:440-8.
28. Legault SE, Langer A, Armstrong PW, Freeman MR. Usefulness of ischemic response to mental stress in predicting silent myocardial ischemia during ambulatory monitoring. Am J Cardiol 1995;75:1007-11.
29. Breisblatt WM, Wolf CJ, McElhinny B, Salerni R, Smith VE. Comparison of ambulatory left ventricular ejection fraction and blood pressure in systemic hypertension in patients with and without increased left ventricular mass. Am J Cardiol 1991;67:597-603.
30. Taki J, Nakajima K, Shimizu M, Tonami N, Hisada K. Left ventricular functional reserve in nonobstructive hypertrophic cardiomyopathy: evaluation by continuous left ventricular function monitoring. J Nucl Med 1994;35:1937-43.
31. Nappi A, Cuocolo A, Iazzetta N, Ferrara LA, Marotta T, Pace L, et al. Ambulatory monitoring of left ventricular function in patients with Parkinson's disease and postural hypotension. Eur J Nucl Med 1994;21:1312-7.
32. Rozanski A, Bairey CN, Krantz DS, Friedman J, Resser KJ, Morell M, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 1988;318:1005-12.
33. Bairey CN, DeQuattro V, Berman DS, Rozanski A. Effect of beta blockade on low heart rate-related ischemia during mental stress. J Am Coll Cardiol 1991;17:1388-95.
34. Ironson G, Taylor CB, Boltwood M, Bartzokis T, Dennis C, Chesney M, et al. Effects of anger on left ventricular ejection fraction in coronary artery disease. Am J Cardiol 1992;70:281-5.
35. Blumenthal JA, Jiang W, Waugh RA, Frid DJ, Morris JJ, Coleman E, et al. Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life: association and hemodynamic features. Circulation 1995;92:2101-8.
36. Yang L, Bairey CN, Berman, DS, Nichols KJ, Odom-Maryon T, Rozanski A. Accuracy and reproducibility of left ventricular ejection fraction measurement using an ambulatory radionuclide left ventricular function monitor. J Nucl Med 1991:32:796-802.
37. Breisblatt WM, McLain JR, Tomlinson GS, Burns MJ, Spaccavento LF. Usefulness of ambulatory radionuclide monitoring of left ventricular function early after acute myocardial ischemia. Am J Cardiol 1988;62:1005-10.
38. Deanfield JE, Shea M, Kensett M. Silent ischemia due to mental stress. Lancet 1984;2:1001-5.
39. Giubbini R, Galli M, Capini R, Bosimini E, Bencivelli W, Tavazzi L. Effects of mental stress on myocardial perfusion in patients with ischemic heart disease. Circulation 1991;83(Suppl II):II100-7.
40. Gottdiener JS, Krantz DS, Howell RH, Hecht GM, Klein J, Falconer JJ, et al. Induction of silent myocardial ischemia with mental stress testing: relation to the triggers of ischemia during daily life activities and to ischemic functional severity. J Am Coll Cardiol 1994;4:1645-51.
41. Jain D, Burg M, Soufer R, Zaret BL. Prognostic implications of mental stress-induced silent left ventricular dysfunction in patients with stable angina pectoris. Am J Cardiol 1995;76:31-5.
42. Stokely EM, Buja LM, Lewis SE, et al. Measurement of acute myocardial infarcts in dogs with 99mTc-stannous pyrophosphate scintigrams. J Nucl Med 1996;17:1-5.
43. Botvinick EH, Shames D, Lappin H, et al. Noninvasive quantitation of myocardial infarction with technetium-99 pyrophosphate. Circulation 1975;52:909-15.
44. Parkey RW, Bonte FJ, Meyer SL, et al. A new method for radionuclide imaging of acute MI in humans. Circulation 1974;50:540-6.
45. Willerson JT, Parkey RW, Bonte FJ, et al. Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology. Circulation 1975;51:1046-52.
46. Poliner LR, Buja LM, Parkey RW, et al. Clinicopathologic findings in 52 patients studied by technetium-99m stannous pyrophosphate myocardial scintigraphy. Circulation 1979;59:257-64.
47. Klausner SC, Botvinick EH, Shames DM, et al. The application of radionuclide infarct scintigraphy to diagnose perioperative myocardial infarction following revascularization. Circulation 1977;56:173-80.
48. Coleman RE, Klein MS, Roberts R, et al. Improved detection of myocardial infarction with technetium-99m stannous pyrophosphate and serum MB creatine phosphokinase. Am J Cardiol 1976;37:732-5.
49. Werner JA, Botvinick EH, Shames DM, et al. Acute myocardial infarction: clinical application of technetium 99m stannous pyrophosphate infarct scintigraphy. West J Med 1977;127:464-78.
50. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, et al: Infarct size after acute myocardial infarction measured by quantitative tomographic 99m-Tc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-41.
51. Ladenheim M, Pollock BH, Rozanski A, Berman DS, Staniloff HS, Forrester JS, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-71.
52. Berman DS, Kiat H, Friedman JD, Diamond G. Clinical applications of exercise nuclear cardiology studies in the era of healthcare reform, a symposium: cardiac imaging. Am J Cardiol 1995;75:11-26.
53. Berman DS, Germano G, Kiat H, Friedman J. Simultaneous perfusion/function imaging [editorial]. J Nucl Cardiol 1995;2:271-3.
54. Lyons KP, Olson HG, Brown WT, et al. Persistence of an abnormal pattern on 99m-Tc pyrophosphate myocardial scintigraphy following acute myocardial infarction. Clin Nucl Med 1976;1:253-7.
55. Ahmed M, Dubiel JP, Logan KW, et al. Limited clinical diagnostic specificity of technetium-99m stannous pyrophosphate myocardial imaging in acute myocardial infarction. Am J Cardiol 1977;3:50-4.
56. Berger H, Alderson L, Becker L, et al. Multicenter trial of In-111 antimyosin for infarct avid imaging. J Nucl Med 1986;27:967-72.
57. Berger H, Lahire A, Leppo J, et al. Antimyosin imaging in patients with ischemic chest pain: initial results of phase III multicenter trial. J Nucl Med 1988;29:1671-80.
58. Khaw BA, Yasuda T, Gold HK, et al. Acute myocardial infarct imaging with indium-111 labeled monoclonal antimyosin Fab. J Nucl Med 1987;28:1671-80.
59. Johnson LL, Seldin DW, Becker LC, et al. Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial. J Am Coll Cardiol 1987;13:27-35.
60. Volpini M, Giubbini R, Gei P, et al. Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localization. Am J Cardiol 1989;63:7-13.
61. Johnson L. Antimyosin imaging in the risk stratification of acute MI. Prim Care 1991;17:55-62.
62. Taillefer R, Lambert R, Dupras G, Gregoire J, Leveille J, Essiambre R, et al. Clinical comparison between thallium-201 and Tc-99m-methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease. Eur J Nucl Med 1989;15:280-6.
63. Heo J, Iskandrian AS. Technetium-labeled myocardial perfusion agents. Cardiol Clin 1994; 12:187-98.
64. Wiersema AM, Oyen WJG, van der Vliet JA, Pak KY, Khaw BA. Evaluation of experimental ischemia and reperfusion damage with Tc-99m glucarate and Tc-99m pyrophosphate [abstract]. J Nucl Med 1996;37:119P.
65. Ramnobaus R, Petrov A, Halder N, Vural I, Pak CYK, Narula J, et al. Subnuclear localization of Tc-99m glucarate in necrotic myocardium [abstract]. J Nucl Med 1996;37:175P.
66. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac tropinins I and T for acute myocardial infarction. Clin Chem 1995;41:1266-72.
67. Manspeaker P, Weisman HF, Schiable TF. Cardiovascular applications: current status of immunoscintigram detection of myocardial necrosis using antimyosin (R11D10) at thrombosis using antifibrin (T2G1s). Semin Nucl Med 1993;23:133-47.
68. Henderson EB, Kahn JK, Corbet, et al. Abnormal I-123 metaidobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192-9.
69. Nakajima K, Taki J, Tonami N, Hisada K. Decreased 123I MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Comm 1994;15:317-23.
70. Merlet P, Valette H, Dubois R, Moyse D, Duboc A, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7.
71. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 1995;26:1594-9.
72. Mitrani R, Klein L, Miles W, Burt R, Wellman H, Zipes D. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993;22:1344-53.
73. Gill J, Hunter G, Gane J, Ward D, Camm A. Asymmetry of cardiac 123I meta-iodobenzylguanidine scans in patients with ventricular tachycardia and a "clinically normal" heart. Br Heart J 1993;69:6-13.
74. Dae M, Ursell P, Lee R, Chin M, Stillson C, Moise N. Heterogeneous sympathetic innervation in german shepherd dogs with inherited ventricular arrhythmia and sudden death [abstract]. J Am Coll Cardiol 1995;25:20A.
75. Wichter T, Hindricks G, Lerch H, Bartenstein P, Borggrefe M, Schober O, et al. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy - an analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation 1994;89: 667-83.
76. Muller K, Jakob H, Neuzner J, Grebe S, Schlepper M, Pitschner H. 123I-metaiodobenzylguanidine scintigraphy in the detection of irregular regional sympathetic innervation in long QT syndrome. Eur Heart J 1993;14:316-25.
77. Tomaselli G, Beuckelmann D, Calkins H, Berger R, Kessler P, Lawrence J, et al. Sudden cardiac death in heart failure - the role of abnormal repolarization. Circulation 1994;90:2534-9.
78. Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1986;316:1429-35.
79. Knapp FF Jr, Kropp J. Iodine-123 labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361-81.
80. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid. J Nucl Med 1992;33:659-67.
81. Taki J, Nakajima K, Masunari I, et al. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischemic but viable myocardium. Eur J Nucl Med 1995;22:1385-92.
82. Nakajima K, Schimizu K, Taki J, et al. Utility of iodine 123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 1995;36:1934-40.
83. Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium. Ann Nucl Med 1994;8:47-54.
84. Tamaki N, Tadamua E, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analog indicated metabolic alterations in ischemic myocardium. J Nucl Med 1995;36:1974-80.
85. Matsunari I, Saga T, Taki J, et al. Improved myocardial fatty acid utilization after percutaneous transmural coronary angioplasty. J Nucl Med 1995;36:1605-7.
86. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 1996;23:272-9.
87. Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994;35:1279-85.
88. Franken P, deGeeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and in tropic reserve. J Nucl Med 1994;35:1758-65.